NEU 8.79% $17.01 neuren pharmaceuticals limited

Share Price, page-11034

  1. 2,824 Posts.
    lightbulb Created with Sketch. 545
    Just a couple of bald facts in relation to the upcoming Acadia earnings call:
    *1-year ago [Q2 2023] Acadia reported a quarterly revenue of $165.2M with Daybue accounting for just 14.0% of that total.
    *The difference between 18 analyst average revenue estimates for the quarter 1-year later[$235.4M for Q2 2024] is $70.2M.This requires an increase in revenue of 42.4%[say about $18M per quarter] for the the full year to meet consensus estimates..
    *In Q1 2024 Daybue revenue alone was $75.9M [in a quarter with seasonal issues].These numbers suggest that if the wheels have not entirely come off either of Acadias two revenue streams then the achievement of the indicated revenue price targets is entirely feasable.
    *My understanding is that there is no Q2 2024 revenue guidance for Daybue revenue.
    Kens
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$17.01
Change
-1.640(8.79%)
Mkt cap ! $2.174B
Open High Low Value Volume
$18.15 $18.18 $16.87 $19.94M 1.159M

Buyers (Bids)

No. Vol. Price($)
3 5090 $17.00
 

Sellers (Offers)

Price($) Vol. No.
$17.10 995 1
View Market Depth
Last trade - 16.10pm 05/08/2024 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.